Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

News & Events

Ten Day Continuous Glucose Monitoring study – now recruiting

The Children’s Diabetes Centre is now recruiting for a new continuous glucose monitoring study.

News & Events

Camp volunteers needed

Diabetes WA is looking for volunteers to take part in the PMH and Diabetes WA Camp for 9 and 10 year olds in Hillarys in September.

News & Events

Farewell Tarini

After nearly two-and-a-half years in sunny Perth, Dr Tarini Chetty is headed back home to Scotland. Before she departs our shores.

News & Events

ENDIA milestone

The ENDIA study — Australia’s largest study into the causes of Type 1 Diabetes— reached a significant milestone when it recruited its 700th patient in Perth.

Centre of Excellence

The Rio Tinto Children’s Diabetes Centre; a Breakthrough T1D Centre of Excellence at The Kids Research Institute Australia and Perth Children’s Hospital (PCH), is a global hub for research into type 1 diabetes (T1D) in children.

Resources

Find newsletters, guidelines, publications and videos in the one spot.

Sport Resources

People living with Type 1 diabetes (T1D) can participate in all forms of physical activity, but it can sometimes be a little more challenging.

Community of Practice

Our goal is to accelerate the dissemination and implementation of evidence-based models of care for children and young people living with Type 1 Diabetes.

Infectious Disease Ecology and Modelling

The Infectious Disease Ecology and Modelling team led by Professor Nick Golding, combines mathematical and statistical modelling, ecology, and public health to address malaria and other infectious and vector-borne diseases. The team uses modelling and maps to measure the risk posed by some of the world’s most important and neglected diseases – including malaria, Japanese Encephalitis Virus and Covid-19 – and provide rapid modelling analyses to policy makers.

Strep A & ARF Therapeutics

The Strep A & ARF Therapeutics research team are working to accelerate research and clinical trials to improve penicillin formulation and treatment methods, to end RHD.